ViiV Healthcare Targets Youth HIV Awareness with 'Still Here' Campaign
Event summary
- ViiV Healthcare launched the 'Still Here' social media video campaign on April 10, 2026, coinciding with National Youth HIV/AIDS Awareness Day.
- The campaign aims to address the 20% of new HIV diagnoses among young people aged 13-24, with 73% of 18-24-year-olds never tested for HIV.
- Black youth accounted for 50% of new HIV youth diagnoses in 2022, highlighting disproportionate impact.
- ViiV Healthcare emphasizes the role of long-acting injectables (LAIs) in HIV treatment and prevention.
The big picture
ViiV Healthcare's 'Still Here' campaign underscores the persistent challenges in HIV prevention and treatment among young people, particularly in marginalized communities. The initiative aligns with broader industry trends towards targeted public health campaigns and innovative treatment solutions. As a global specialist HIV company, ViiV Healthcare's efforts highlight the critical role of pharmaceutical companies in addressing public health issues through both medical innovation and community engagement.
What we're watching
- Campaign Effectiveness
- Whether the 'Still Here' campaign can successfully engage young people and increase HIV awareness and testing rates.
- Disproportionate Impact
- The pace at which ViiV Healthcare can address the disproportionate impact of HIV on Black youth through targeted initiatives.
- Innovation Leadership
- How ViiV Healthcare's focus on long-acting injectables will influence the future of HIV treatment and prevention.
Related topics